Stryker Q3 FY26: where the revenue came from and where it went
The whole income statement of Stryker for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2026
- Reported
- Oct 30, 2026
Revenue$6.52B
+8% year over year
Gross profit$4.25B
65% margin
Operating profit$1.03B
16% margin
Net profit$0.75B
12% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 6.52 | 100% | +8% |
| Med surg & neurotechnology | 3.66 | 56% | |
| Orthopaedics & spine | 2.86 | 44% | |
| Cost of revenue | −2.27 | 35% | |
| Gross profit | 4.25 | 65% margin | +2pp |
| R&D | −0.43 | 7% | +0pp |
| SG&A | −2.31 | 35% | +2pp |
| Other | −0.47 | 7% | |
| Operating profit | 1.03 | 16% margin | −3pp |
| Interest & other costs | −0.04 | ||
| Tax | −0.24 | ||
| Net profit | 0.75 | 12% margin | −3pp |
3 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest